查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1779909

帕金森氏症深部脑部刺激疗法的全球市场

Deep Brain Stimulation in Parkinson's Disease
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，巴金森氏症深部脑部刺激全球市场规模将达到 15 亿美元

帕金森氏症深部脑部刺激全球市场规模预计在2024年达到8.825亿美元，预计在分析期间（2024-2030年）将以8.7%的复合年增长率增长，到2030年将达到15亿美元。双通道深部脑部刺激是本报告分析的细分市场之一，预计其复合年增长率将达到10.2%，到分析期结束时达到9.538亿美元。单通道深部脑部刺激细分市场在分析期间的复合年增长率预计为6.2%。

美国市场规模估计为 2.404 亿美元，中国市场预计复合年增长率为 13.8%

预计到2024年，美国帕金森氏症深部脑部刺激市场规模将达2.404亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.222亿美元，在2024-2030年的分析期间内，复合年增长率为13.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.3%和8.4%。在欧洲，预计德国市场的复合年增长率为5.8%。

帕金森氏症深部脑部刺激的全球市场—主要趋势和驱动因素摘要

深部脑部刺激是帕金森氏症治疗的未来吗？

深部脑部刺激 (DBS) 已成为帕金森氏症的突破性治疗方法，为经历运动波动和药物难治症状的患者带来新希望。这种神经外科手术包括在大脑的特定区域植入电极并传递受控电脉衝来调节异常神经活动。多年来，DBS 技术取得了显着发展，更新、更精确的系统改善了患者的预后。传统的帕金森氏症药物，如左旋多巴，通常会随着时间的推移而变得不那么有效，并导致使人衰弱的运动併发症。 DBS 提供了一种长期解决方案，可减少震颤、僵硬和运动障碍，并提高生活品质。微创手术技术和增强的即时神经影像学提高了 DBS 手术的安全性和准确性。此外，对自适应 DBS（根据大脑活动动态调整刺激水平）的研究为个人化治疗策略打开了新的大门。

科技进步如何增强深部脑部刺激？

深部脑电刺激 (DBS) 技术的进步显着提高了精准度、安全性和病患舒适度。可充电和相容 MRI 设备的引入延长了设备的使用寿命，并减少了频繁更换的需求。闭合迴路DBS 系统基于神经反馈即时调整刺激参数，透过提供更个人化和高效的治疗，正在彻底改变该领域。此外，人工智慧和机器学习正在整合到 DBS 编程中，使临床医生能够以前所未有的精度优化刺激设定。无线编程和远端监控功能的出现也简化了术后管理，使神经科无需频繁就诊即可追踪患者的病情进展。这些进步不仅改善了临床疗效，也支持 DBS 在更广泛的患者群体中广泛应用。

是什么推动了帕金森氏症患者广泛采用 DBS？

帕金森氏症患者病率的不断上升，加上全球人口老化，推动了对深部脑电刺激 (DBS) 等先进治疗方案的需求。随着越来越多的临床试验检验了DBS 的长期有效性和安全性，医生开始建议在病情发展早期进行手术，而不是将其作为最后的治疗手段。患者对非药物介入措施的认知度不断提高，也有助于提高此疗法的采用率。此外，手术机器人和电极置入技术的改进降低了手术相关风险，使其成为更广泛患者的可行选择。政府和医疗机构也逐渐认识到 DBS 的益处，从而加强了保险覆盖范围和报销政策，使其成为一种经济实惠的治疗方法。

帕金森氏症深部脑部刺激市场的成长受到多种因素的推动...

深部脑电刺激 (DBS) 市场的成长受到多种因素的推动，包括技术的快速进步、帕金森氏症患者病率的上升以及人们对非侵入性长期治疗方案日益增长的偏好。主导的闭合迴路刺激系统的发展提高了治疗的精确度，使 DBS 能够惠及更广泛的患者。专科神经病学医疗基础设施的扩展以及神经技术研究投入的增加也在市场扩张中发挥关键作用。此外，越来越多的监管部门核准和优惠的报销政策正在鼓励越来越多的医院和诊所采用 DBS 作为帕金森氏症的标准治疗方法。个人化医疗的推动，即根据患者的独特需求调整刺激参数，也是推动市场向前发展的主要因素。

部分

产品（双通道深部脑部刺激、单通道深部脑部刺激）、最终使用者（医院最终使用者、门诊手术中心最终使用者、神经科科诊所最终使用者、研究中心最终使用者）

受访公司范例

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Beijing PINS Medical Co., Ltd.
  • Boston Scientific
  • BrainsWay Ltd.
  • DBS Technologies Pty Ltd
  • Epi-Minder
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Functional Neuromodulation Ltd.
  • InBrain Neuroelectronics
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic
  • Neo-Bionica
  • Neuroelectrics
  • NeuroPace, Inc.
  • Pulsetto
  • Renishaw PLC

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP30395

Global Deep Brain Stimulation in Parkinson's Disease Market to Reach US$1.5 Billion by 2030

The global market for Deep Brain Stimulation in Parkinson's Disease estimated at US$882.5 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Dual-Channel Deep Brain Stimulation, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$953.8 Million by the end of the analysis period. Growth in the Single-Channel Deep Brain Stimulation segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$240.4 Million While China is Forecast to Grow at 13.8% CAGR

The Deep Brain Stimulation in Parkinson's Disease market in the U.S. is estimated at US$240.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$322.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Deep Brain Stimulation in Parkinson’s Disease Market - Key Trends & Drivers Summarized

Is Deep Brain Stimulation the Future of Parkinson’s Disease Treatment?

Deep Brain Stimulation (DBS) has emerged as a groundbreaking treatment for Parkinson’s disease, offering new hope to patients experiencing motor fluctuations and medication-resistant symptoms. This neurosurgical procedure involves implanting electrodes into specific brain regions, delivering controlled electrical impulses to modulate abnormal neural activity. Over the years, DBS technology has significantly evolved, with newer, more precise systems improving patient outcomes. Traditional pharmacological treatments for Parkinson’s disease, such as levodopa, often become less effective over time, leading to debilitating motor complications. DBS provides a long-term solution, reducing tremors, rigidity, and dyskinesia, thereby improving quality of life. The rise in minimally invasive surgical techniques and real-time neuroimaging has enhanced the safety and accuracy of DBS procedures. Additionally, research into adaptive DBS, which adjusts stimulation levels dynamically based on brain activity, is opening new doors for personalized treatment strategies.

How Are Technological Advancements Enhancing Deep Brain Stimulation?

Advancements in DBS technology have dramatically improved precision, safety, and patient comfort. The introduction of rechargeable and MRI-compatible implants has increased the longevity of devices, reducing the need for frequent replacements. Closed-loop DBS systems, which adjust stimulation parameters in real time based on neural feedback, are revolutionizing the field by providing more tailored and efficient treatment. Furthermore, AI and machine learning are being integrated into DBS programming, allowing physicians to optimize stimulation settings with unprecedented accuracy. The emergence of wireless programming and remote monitoring capabilities is also making post-surgical management more efficient, enabling neurologists to track patient progress without requiring frequent hospital visits. These advancements are not only enhancing clinical outcomes but also expanding the accessibility of DBS to a broader patient base.

What Is Driving the Growing Adoption of DBS in Parkinson’s Patients?

The increasing prevalence of Parkinson’s disease, coupled with an aging global population, is driving the demand for advanced treatment options like DBS. As more clinical trials validate the long-term efficacy and safety of DBS, physicians are recommending the procedure earlier in disease progression rather than as a last-resort treatment. The growing awareness among patients about non-pharmacological interventions has also contributed to higher adoption rates. Additionally, improvements in surgical robotics and electrode placement techniques have reduced the risks associated with the procedure, making it a more viable option for a wider range of patients. Governments and healthcare organizations are also recognizing the benefits of DBS, leading to increased insurance coverage and reimbursement policies that make the treatment more financially accessible.

The Growth in the Deep Brain Stimulation in Parkinson’s Disease Market Is Driven by Several Factors…

The growth in the DBS market is driven by several factors, including rapid technological advancements, the rising incidence of Parkinson’s disease, and an increasing preference for non-invasive, long-term treatment solutions. The development of AI-driven and closed-loop stimulation systems is enhancing treatment precision, making DBS more effective for a broader range of patients. The expansion of neurology-focused healthcare infrastructure and increasing investments in neurotechnology research are also playing a crucial role in market expansion. Furthermore, the rising number of regulatory approvals and favorable reimbursement policies are encouraging more hospitals and clinics to adopt DBS as a standard Parkinson’s treatment. The push toward personalized medicine, where stimulation parameters are adjusted based on patient-specific needs, is another major driver propelling the market forward.

SCOPE OF STUDY:

The report analyzes the Deep Brain Stimulation in Parkinson's Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Dual-Channel Deep Brain Stimulation, Single-Channel Deep Brain Stimulation); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use, Research Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Beijing PINS Medical Co., Ltd.
  • Boston Scientific
  • BrainsWay Ltd.
  • DBS Technologies Pty Ltd
  • Epi-Minder
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Functional Neuromodulation Ltd.
  • InBrain Neuroelectronics
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic
  • Neo-Bionica
  • Neuroelectrics
  • NeuroPace, Inc.
  • Pulsetto
  • Renishaw PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Deep Brain Stimulation in Parkinson's Disease - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Parkinson's Disease Throws the Spotlight on Advanced Neuromodulation Therapies
    • Growing Patient Eligibility and Early Diagnosis Spur Demand for Deep Brain Stimulation (DBS) Interventions
    • Technological Advancements in Directional Leads and Closed-Loop Systems Strengthen the Business Case for DBS
    • Improved Battery Life and Rechargeable Implant Systems Enhance Patient Compliance and Quality of Life
    • Increasing Neurologist Awareness and Surgical Training Expand Accessibility to DBS Across Care Settings
    • FDA and CE Approvals of Next-Generation Devices Accelerate Market Penetration in Key Regions
    • Growing Evidence Base for DBS in Non-Motor Symptoms Propels Broader Use Across PD Patient Segments
    • Insurance Reimbursement and Coverage Expansion Support Affordability in Advanced Parkinson's Care
    • Adoption of MRI-Compatible Devices Reduces Risk and Facilitates Post-Surgical Monitoring
    • Wearable and App-Based Patient Tracking Tools Integrate with DBS Systems for Outcome Optimization
    • Minimally Invasive Surgical Techniques Reduce Recovery Time and Improve Patient Uptake
    • DBS Research in Younger-Onset Parkinson's and Genetic Cases Opens New Treatment Frontiers
    • Public-Private Research Initiatives Drive Investment and Innovation in Neuromodulation Platforms
    • Growing Global Burden of Neurological Disorders Supports Long-Term Growth in DBS Infrastructure
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Deep Brain Stimulation in Parkinson's Disease Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dual-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Single-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neurology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION